FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2907610963> ?p ?o ?g. }

• W2907610963 abstract "Clinical efficacy and adverse reactions of pemetrexed combined with stereotactic gamma-ray radiotherapy in the treatment of patients with lung adenocarcinoma brain metastasis in The First People's Hospital of Yunnan Province were evaluated. A total of 67 patients with lung adenocarcinoma brain metastasis in experimental group were treated with simple pemetrexed chemotherapy, and then with radiotherapy, followed by pemetrexed chemotherapy. Their treatment results were compared with those of 53 patients treated with simple gamma knife in control group. The results were analyzed by comparing the clinical efficacy, side reactions, serum level changes, and survival between the two groups. Among 67 patients in the experimental group, there were 16 cases of complete response (CR), 39 cases of partial response (PR), 7 cases of stable disease (SD) and 5 cases of progressive disease (PD), with an effective rate of 82.09% (55/67) and a tumor local control rate of 92.54% (62/67). Among 53 patients in the control group, there were 13 cases of CR, 20 cases of PR, 9 cases of SD and 11 cases of PD, with an effective rate of 62.26% (33/53) and a tumor local control rate of 79.25% (42/53). There were statistically significant differences in the effective rate and local control rate between the two groups (P<0.05). The 6-, 12- and 24-month survival rates in experimental group were higher than those in control group (P<0.05). The main adverse reactions after pemetrexed combined with radiotherapy were lower than those after simple radiotherapy (P<0.05). The expression levels of the tumor markers carcinoembryonic antigen (CEA) and cytokeratin fragment antigen 21-1 (CYFRA21-1) in the two groups of patients after treatment were lower than those before treatment (P<0.05). After treatment, the expression levels of serum CEA and CYFRA21-1 in the experimental group were significantly lower than those in the control group (P<0.05). Pemetrexed combined with radiotherapy in the treatment of lung adenocarcinoma brain metastasis is more effective than simple radiotherapy, with lighter adverse reactions, worthy of clinical application and promotion." @default.
• W2907610963 created "2019-01-11" @default.
• W2907610963 creator A5005764524 @default.
• W2907610963 creator A5007339859 @default.
• W2907610963 creator A5040505100 @default.
• W2907610963 creator A5042470910 @default.
• W2907610963 creator A5073531557 @default.
• W2907610963 creator A5075090862 @default.
• W2907610963 date "2019-01-04" @default.
• W2907610963 modified "2023-09-26" @default.
• W2907610963 title "Clinical efficacy and safety evaluation of pemetrexed combined with radiotherapy in treatment of patients with lung adenocarcinoma brain metastasis" @default.
• W2907610963 cites W1506255673 @default.
• W2907610963 cites W1812211410 @default.
• W2907610963 cites W1896982762 @default.
• W2907610963 cites W1968421135 @default.
• W2907610963 cites W1992800612 @default.
• W2907610963 cites W1999896690 @default.
• W2907610963 cites W2019680389 @default.
• W2907610963 cites W2022364048 @default.
• W2907610963 cites W2041146056 @default.
• W2907610963 cites W2065437218 @default.
• W2907610963 cites W2070002280 @default.
• W2907610963 cites W2075321890 @default.
• W2907610963 cites W2076855156 @default.
• W2907610963 cites W2078419129 @default.
• W2907610963 cites W2105581224 @default.
• W2907610963 cites W2105776276 @default.
• W2907610963 cites W2112362471 @default.
• W2907610963 cites W2116142233 @default.
• W2907610963 cites W2116478428 @default.
• W2907610963 cites W2119122865 @default.
• W2907610963 cites W2126427337 @default.
• W2907610963 cites W2127465345 @default.
• W2907610963 cites W2128990677 @default.
• W2907610963 cites W2140356034 @default.
• W2907610963 cites W2183542771 @default.
• W2907610963 cites W2225079860 @default.
• W2907610963 cites W2235523093 @default.
• W2907610963 cites W2314674621 @default.
• W2907610963 cites W2472958455 @default.
• W2907610963 cites W2604611032 @default.
• W2907610963 cites W2607919932 @default.
• W2907610963 cites W2613517658 @default.
• W2907610963 cites W2915371318 @default.
• W2907610963 cites W4255665441 @default.
• W2907610963 doi "https://doi.org/10.3892/ol.2019.9894" @default.
• W2907610963 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6365961" @default.
• W2907610963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30854063" @default.
• W2907610963 hasPublicationYear "2019" @default.
• W2907610963 type Work @default.
• W2907610963 sameAs 2907610963 @default.
• W2907610963 citedByCount "1" @default.
• W2907610963 countsByYear W29076109632022 @default.
• W2907610963 crossrefType "journal-article" @default.
• W2907610963 hasAuthorship W2907610963A5005764524 @default.
• W2907610963 hasAuthorship W2907610963A5007339859 @default.
• W2907610963 hasAuthorship W2907610963A5040505100 @default.
• W2907610963 hasAuthorship W2907610963A5042470910 @default.
• W2907610963 hasAuthorship W2907610963A5073531557 @default.
• W2907610963 hasAuthorship W2907610963A5075090862 @default.
• W2907610963 hasBestOaLocation W29076109631 @default.
• W2907610963 hasConcept C121608353 @default.
• W2907610963 hasConcept C126322002 @default.
• W2907610963 hasConcept C141071460 @default.
• W2907610963 hasConcept C143998085 @default.
• W2907610963 hasConcept C197934379 @default.
• W2907610963 hasConcept C2776256026 @default.
• W2907610963 hasConcept C2776283816 @default.
• W2907610963 hasConcept C2776694085 @default.
• W2907610963 hasConcept C2777240266 @default.
• W2907610963 hasConcept C2778164965 @default.
• W2907610963 hasConcept C2778239845 @default.
• W2907610963 hasConcept C2778822529 @default.
• W2907610963 hasConcept C2779013556 @default.
• W2907610963 hasConcept C2781182431 @default.
• W2907610963 hasConcept C509974204 @default.
• W2907610963 hasConcept C71924100 @default.
• W2907610963 hasConcept C90924648 @default.
• W2907610963 hasConceptScore W2907610963C121608353 @default.
• W2907610963 hasConceptScore W2907610963C126322002 @default.
• W2907610963 hasConceptScore W2907610963C141071460 @default.
• W2907610963 hasConceptScore W2907610963C143998085 @default.
• W2907610963 hasConceptScore W2907610963C197934379 @default.
• W2907610963 hasConceptScore W2907610963C2776256026 @default.
• W2907610963 hasConceptScore W2907610963C2776283816 @default.
• W2907610963 hasConceptScore W2907610963C2776694085 @default.
• W2907610963 hasConceptScore W2907610963C2777240266 @default.
• W2907610963 hasConceptScore W2907610963C2778164965 @default.
• W2907610963 hasConceptScore W2907610963C2778239845 @default.
• W2907610963 hasConceptScore W2907610963C2778822529 @default.
• W2907610963 hasConceptScore W2907610963C2779013556 @default.
• W2907610963 hasConceptScore W2907610963C2781182431 @default.
• W2907610963 hasConceptScore W2907610963C509974204 @default.
• W2907610963 hasConceptScore W2907610963C71924100 @default.
• W2907610963 hasConceptScore W2907610963C90924648 @default.
• W2907610963 hasLocation W29076109631 @default.
• W2907610963 hasLocation W29076109632 @default.
• W2907610963 hasLocation W29076109633 @default.
• W2907610963 hasLocation W29076109634 @default.
• W2907610963 hasOpenAccess W2907610963 @default.

• next